Investor Presentaiton
Important Notice and Disclaimer
This investor presentation (Presentation) is dated 26 July 2021 and has been prepared by Aroa Biosurgery Limited (NZ Company number 1980577 / ARBN 638 867 473) (AROA, ARX or the
Company) in connection with a proposed capital raising and includes information regarding an institutional placement and share purchase plan of new fully paid ordinary shares in AROA
(New Shares) (Offer)
Summary information
The information in this Presentation is of a general background nature, is in summary form and does not purport to be complete. It does not contain all information relevant or necessary for
an investment decision or that would be required to be included in a prospectus under the Corporations Act 2001 (Cth) (Corporations Act) for an offer of securities in Australia. It should be
read in conjunction with AROA's most recent financial report and other periodic and continuous disclosure announcements lodged with the Australian Securities Exchange (ASX) available at
www.asx.com.au. The content of this Presentation is provided as at the date of this Presentation (unless otherwise stated). The information in this Presentation is subject to change without
notice. No representation or warranty, express or implied, is made by AROA or any of its advisers as to the accuracy, adequacy or reliability of any information contained in this Presentation.
Not a prospectus or an offer of securities
This Presentation is not a prospectus or any other offering document under Australian law (and will not be lodged with the Australian Securities and Investments Commission (ASIC)) or under
the law of any other jurisdiction in which an offer of New Shares may be received. This Presentation is for information purposes only and is not an invitation or offer of securities for
subscription, purchase or sale in any jurisdiction. The distribution of this Presentation outside Australia may be restricted by law. Any recipient of this Presentation who is outside Australia
must seek advice on and observe any such restrictions. Recipients of this Presentation in Hong Kong and New Zealand, should carefully read the international offer restriction statements in
this Presentation. This Presentation may not be reproduced or published, in whole or in part, for any purpose without the prior written permission of AROA.
Not for release or distribution in the United States of America
This Presentation may not be distributed or released in the United States of America or to any person acting for the account or benefit of a person in the United States of America. This
Presentation does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States of America or any other jurisdiction in which such an offer would be
illegal. The securities referred to in this Presentation have not been, and will not be, registered under the U.S. Securities Act of 1933 as amended (the Securities Act) or the securities laws of
any state or other jurisdiction of the United States of America and may not be offered or sold, directly or indirectly, in the United States of America or to any person acting for the account or
benefit of a person in the United States of America, unless the securities have been registered under the Securities Act (which AROA has no obligation to do or procure) or are offered and sold
in a transaction exempt from, or not subject to, the registration requirements of the Securities Act and any other applicable securities laws, of any state or other jurisdiction in the United States
of America.
Each institution that reviews the information contained in this Presentation that is in the United States, or that is acting for the account or benefit of a person in the United States, will be
deemed to represent (x) that each such institution or person is either (1) an institutional "accredited investor" or (2) a dealer or other professional fiduciary organised or incorporated in the
United States that is acting for an account (other than an estate or trust) held for the benefit or account of persons that are not "U.S. persons" (as defined in Rule 902(k) of the Securities Act)
for which they have, and are exercising, investment discretion, within the meaning of Rule 902(k)(2)(i) of Regulation S, and (y) agree that it will not forward or deliver this Presentation,
electronically or otherwise, to any other person.
TM
AROA
2View entire presentation